Sidley is honored to announce its membership in the Digital Therapeutics Alliance (DTA) Resource Partner Program. The purpose of DTA’s Resource Partner Program is to accelerate the development and post-launch success of clinically-validated digital therapeutics through collaborations among DTA’s member task groups.
The firm is glad to support DTA’s member task group’s commercial acceleration initiatives, including engaging in the launch of the DTx Assessment and Integration Guide.
Sidley’s digital health platform is at the forefront of developing value-based market access strategies to champion broad adoption of pioneering therapeutic technologies.
Sidley partners Meena Datta and Beth Hardcastle are supporting DTA’s payor adoption efforts.